A recent report published by Infinium Global Research on embolotherapy market provides an in-depth analysis of segments and sub-segments in the global as well as regional embolotherapy industry
Pune, India -- (SBWIRE) -- 11/26/2019 -- The Infinium Global Research analyzes the "Embolotherapy Market (Product - Embolic Agents, and Support Devices; Disease - Oncology, Peripheral Vascular, Gastrointestinal Disorders, and Other Diseases; End-user - Hospitals, Clinics, Academia, and Ambulatory Surgical Centers): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025". Embolotherapy is an endovascular treatment that occludes abnormal blood vessels to control bleeding, reduce tumors, and much more. Embolotherapy is becoming the pillars of interventional radiology practice. As the field covers such a wide range of treatment possibilities. The report provides in-depth information about the embolotherapy market which is expected to grow at a CAGR of 8.0% over the forecast period of 2019-2025.
For More Details Get FREE Sample Pages of this Research Report@ https://www.infiniumglobalresearch.com/reports/sample-request/15248
Growing Research and Development Investments Propel the Embolotherapy Industry Growth
The rising prevalence of peripheral vascular diseases, strokes, liver cancer, and uterine fibroids drives the growth of the embolotherapy market. The increasing demand for minimally invasive procedures contributes to the growth of the embolotherapy market. The growing research and development investments propel the embolotherapy market growth. The rising geriatric population stimulates the growth of the embolotherapy market. In addition, the favorable reimbursement scenario in the market boosts the growth of the embolotherapy market. On the flip side, strict regulations for product commercialization hamper the growth of the embolotherapy market. Moreover, technological development in the healthcare sector creates numerous opportunities for the growth of the embolotherapy market.
Embolotherapy Market is Segmented on the Basis of Product, Disease, And End-Use
The global embolotherapy market is segmented on the basis of product, disease, and end-use. The product segment is divided into embolic agents and support devices. The embolic agents include embolic coils, liquid embolic agents, embolic plug systems, microspheres, and detachable balloons. Microspheres are expected to have the largest share in the embolic agents' segment of the embolotherapy market owing to rising incidences of hepatocellular carcinoma which is treated with microspheres. The support devices sub-segment is further divided into microcatheters and guidewires. Based on disease, the embolotherapy market is divided into oncology, peripheral vascular, gastrointestinal disorders, and other diseases. The oncology segment is expected to dominate the diseased segment of the embolotherapy market due to the growing prevalence of liver and kidney cancer. The end-user segment includes hospitals, clinics, academia, and ambulatory surgical centers.
Request a Discount on Standard Prices of this Premium Report @ https://www.infiniumglobalresearch.com/reports/request-discount/15248
North America Region is Projected to Account for the Largest Share in the Embolotherapy Market During the Forecast Period
Geographically, the global embolotherapy market is divided into North America, Asia-Pacific, Europe, and the Rest of the World. North America is expected to hold a premium share in the global embolotherapy market. The rising adoption of minimally invasive methods and growing technological development in embolotherapy equipment in North America contribute to the growth of the embolotherapy market. Asia-Pacific region is anticipated to grow in the global embolotherapy market with a healthy CAGR over the forecast period. The rising healthcare infrastructure and the prevalence of target diseases in the Asia-Pacific region drive the growth of the embolotherapy market. Europe is growing in the global embolotherapy market.
Embolotherapy Market: Competitive Landscape
The key players in the global embolotherapy market are Balt Extrusion SAS, Medtronic plc, Merit Medical Systems, Inc., Penumbra, Inc., Terumo Medical Corporation, Stryker Corporation, Kaneka Corporation, Abbott Laboratories S.A., Acandis GmbH & Co KG, Boston Scientific Corporation, and other companies. The leading companies in the global embolotherapy market are using strategies such as mergers, acquisitions, and new product launches that contribute to the growth of market share in the embolotherapy market.
Browse Detailed TOC and Description of "Embolotherapy Market"
Reasons to Buy this Report:
=> Comprehensive analysis of global as well as regional markets of the embolotherapy.
=> Complete coverage of all the product type and application segments to analyze the trends, developments, and forecast of market size up to 2025.
=> Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.
=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.